Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.
There will be four study groups:
There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Heart patients who experienced a cardiac arrhythmia while in hospital | Heart patients who experienced a cardiac arrhythmia while in hospital |
| |
| Heart patients who did not experience a cardiac arrhythmia while in hospital | Heart patients who did not experience a cardiac arrhythmia while in hospital |
| |
| Heart patients with an upcoming procedure that have not had a cardiac arrhythmia | Heart patients with an upcoming procedure that have not had a cardiac arrhythmia |
| |
| Members of the general public | Members of the general public |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Surveys | Other | Surveys to evaluate prior experience, opinions and intervention acceptability. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey | accept a biological therapy | 2 years |
Not provided
Not provided
Inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients will be recruited from in house databases after confirming patients have agreed to participate in research.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Darryl Davis | Ottawa Heart Institute Research Corporation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Ottawa Heart Insitute | Ottawa | Ontario | K1Y4W7 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39026620 | Derived | Smith C, Lalu MM, Davis DR. Exploring Patient Viewpoints to Optimize Implementation of a Biological Therapy for Atrial Fibrillation Prevention. CJC Open. 2024 Apr 16;6(7):893-900. doi: 10.1016/j.cjco.2024.04.003. eCollection 2024 Jul. |
Not provided
Not provided
IPD will not be shared
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D010358 | Patient Participation |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| D017144 | Focus Groups |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Focus group | Other | To answer any questions and discuss topics covered in the standard presentation. |
|
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |